Cargando…
Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation
Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder that results in irreversible renal damage due to 2,8-dihydroxyadenine (DHA) nephropathy. A 28-year-old man underwent living-related kidney transplantation for chronic kidney disease of unknown etiology. Numero...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498204/ https://www.ncbi.nlm.nih.gov/pubmed/28566603 http://dx.doi.org/10.2169/internalmedicine.56.8142 |
_version_ | 1783248270520221696 |
---|---|
author | Nanmoku, Koji Kurosawa, Akira Shinzato, Takahiro Shimizu, Toshihiro Kimura, Takaaki Yagisawa, Takashi |
author_facet | Nanmoku, Koji Kurosawa, Akira Shinzato, Takahiro Shimizu, Toshihiro Kimura, Takaaki Yagisawa, Takashi |
author_sort | Nanmoku, Koji |
collection | PubMed |
description | Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder that results in irreversible renal damage due to 2,8-dihydroxyadenine (DHA) nephropathy. A 28-year-old man underwent living-related kidney transplantation for chronic kidney disease of unknown etiology. Numerous spherical brownish crystals observed in his urinary sediment on postoperative day 3 and were observed within the tubular lumen of renal allograft biopsy specimens on postoperative day 7. After a genetic diagnosis, febuxostat treatment was started on postoperative day 7, with the dosage gradually increased to 80 mg/day until complete the disappearance of 2,8-DHA crystals. Febuxostat prevented secondary 2,8-DHA nephropathy after kidney transplantation. |
format | Online Article Text |
id | pubmed-5498204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-54982042017-07-07 Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation Nanmoku, Koji Kurosawa, Akira Shinzato, Takahiro Shimizu, Toshihiro Kimura, Takaaki Yagisawa, Takashi Intern Med Case Report Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder that results in irreversible renal damage due to 2,8-dihydroxyadenine (DHA) nephropathy. A 28-year-old man underwent living-related kidney transplantation for chronic kidney disease of unknown etiology. Numerous spherical brownish crystals observed in his urinary sediment on postoperative day 3 and were observed within the tubular lumen of renal allograft biopsy specimens on postoperative day 7. After a genetic diagnosis, febuxostat treatment was started on postoperative day 7, with the dosage gradually increased to 80 mg/day until complete the disappearance of 2,8-DHA crystals. Febuxostat prevented secondary 2,8-DHA nephropathy after kidney transplantation. The Japanese Society of Internal Medicine 2017-06-01 /pmc/articles/PMC5498204/ /pubmed/28566603 http://dx.doi.org/10.2169/internalmedicine.56.8142 Text en Copyright © 2017 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Nanmoku, Koji Kurosawa, Akira Shinzato, Takahiro Shimizu, Toshihiro Kimura, Takaaki Yagisawa, Takashi Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
title | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
title_full | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
title_fullStr | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
title_full_unstemmed | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
title_short | Febuxostat for the Prevention of Recurrent 2,8-dihydroxyadenine Nephropathy due to Adenine Phosphoribosyltransferase Deficiency Following Kidney Transplantation |
title_sort | febuxostat for the prevention of recurrent 2,8-dihydroxyadenine nephropathy due to adenine phosphoribosyltransferase deficiency following kidney transplantation |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498204/ https://www.ncbi.nlm.nih.gov/pubmed/28566603 http://dx.doi.org/10.2169/internalmedicine.56.8142 |
work_keys_str_mv | AT nanmokukoji febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation AT kurosawaakira febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation AT shinzatotakahiro febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation AT shimizutoshihiro febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation AT kimuratakaaki febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation AT yagisawatakashi febuxostatforthepreventionofrecurrent28dihydroxyadeninenephropathyduetoadeninephosphoribosyltransferasedeficiencyfollowingkidneytransplantation |